share_log

T2 Biosystems | 8-K: Voting Results of Special Shareholders' Meeting

T2 Biosystems | 8-K: Current report

T2 Biosystems | 8-K：重大事件
美股sec公告 ·  04/12 16:53
Moomoo AI 已提取核心訊息
On April 11, 2024, T2 Biosystems, Inc., a company incorporated in Delaware and listed on the Nasdaq Capital Market under the trading symbol TTOO, held a special meeting of stockholders. The meeting was conducted to vote on the approval of the CRG Debt to Equity Conversion. Stockholders representing approximately 35.86% of the voting power of the issued and outstanding common stock were present either in person via live webcast or by proxy. The proposal for the CRG Debt to Equity Conversion received overwhelming support with 1,684,394 votes for, 60,832 against, and 23,645 abstentions, leading to its approval. The definitive Proxy Statement provided additional information on the proposals submitted to stockholders.
On April 11, 2024, T2 Biosystems, Inc., a company incorporated in Delaware and listed on the Nasdaq Capital Market under the trading symbol TTOO, held a special meeting of stockholders. The meeting was conducted to vote on the approval of the CRG Debt to Equity Conversion. Stockholders representing approximately 35.86% of the voting power of the issued and outstanding common stock were present either in person via live webcast or by proxy. The proposal for the CRG Debt to Equity Conversion received overwhelming support with 1,684,394 votes for, 60,832 against, and 23,645 abstentions, leading to its approval. The definitive Proxy Statement provided additional information on the proposals submitted to stockholders.
2024年4月11日，在特拉華州註冊並在納斯達克資本市場上市，交易代碼爲TTOO的公司T2 Biosystems, Inc. 舉行了一次特別股東會議。舉行這次會議是爲了對批准CRG債轉股進行投票。佔已發行和流通普通股投票權約35.86％的股東通過網絡直播或通過代理人親自出席。CRG債轉股提案獲得壓倒性支持，獲得1,684,394張贊成票，60,832票反對，23,645票棄權，最終獲得批准。最終委託書提供了有關提交給股東的提案的更多信息。
2024年4月11日，在特拉華州註冊並在納斯達克資本市場上市，交易代碼爲TTOO的公司T2 Biosystems, Inc. 舉行了一次特別股東會議。舉行這次會議是爲了對批准CRG債轉股進行投票。佔已發行和流通普通股投票權約35.86％的股東通過網絡直播或通過代理人親自出席。CRG債轉股提案獲得壓倒性支持，獲得1,684,394張贊成票，60,832票反對，23,645票棄權，最終獲得批准。最終委託書提供了有關提交給股東的提案的更多信息。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息